{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:42:36Z","timestamp":1793911356198,"version":"4.8.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This committee statement announces the American College of Obstetricians &amp; Gynecologists\u2019 qualified endorsement of the 2026 Women's Preventive Services Initiative's (WPSI) updated cervical cancer screening guidelines and addresses cervical cancer screening for patients at average risk in the following age categories: 21\u201329 years, 30\u201365 years, and older than 65 years. This committee statement discusses specific qualifications to the WPSI guidelines, particularly regarding self-collection for primary high-risk human papillomavirus screening, among other implementation considerations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006257","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:04:42Z","timestamp":1776978282000},"page":"e63-e67","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["ACOG Committee Statement No. 28: Screening for Cervical Cancer"],"prefix":"10.1097","volume":"148","author":[{"name":"American College of Obstetricians & Gynecologists' Committee on Clinical Consensus\u2013Gynecology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"R2-20260930","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors [published erratum appears in J Low Genit Tract Dis 2020;24:427]","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R3-20260930","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/LGT.0000000000000802","article-title":"Recommendations for use of p16\/Ki67 dual stain for management of individuals testing positive for human papillomavirus [published erratum appears in J Low Genit Tract Dis 2024;28:316]","volume":"28","author":"Clarke","year":"2024","journal-title":"J Low Genit Tract Dis"},{"key":"R4-20260930","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/LGT.0000000000000865","article-title":"Applying results of extended genotyping to management of positive cervicovaginal human papillomavirus test results: enduring guidelines","volume":"29","author":"Massad","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"R5-20260930","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R6-20260930","first-page":"e70041","article-title":"Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: an update to the American Cancer Society cervical cancer screening guideline [published erratum appears in CA Cancer J Clin 2026;76:e70066]","volume":"76","author":"Perkins","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"R9-20260930","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/LGT.0000000000000885","article-title":"Self-collected vaginal specimens for HPV testing: recommendations from the enduring consensus cervical cancer screening and management guidelines committee","volume":"29","author":"Wentzensen","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"R10-20260930","doi-asserted-by":"crossref","first-page":"106400","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups","volume":"144","author":"Fuzzell","year":"2021","journal-title":"Prev Med"},{"key":"R11-20260930","first-page":"229","article-title":"A review of cervical cancer: incidence and disparities","volume":"112","author":"Buskwofie","year":"2020","journal-title":"J Natl Med Assoc"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:00:42Z","timestamp":1790784042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006257","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}